Furthermore, in a univariate analysis, patients with breast cancer with tumors expressing high mRNA levels of MELK had significantly reduced PFS, DMFS, and OS compared with patients with tumors expressing low levels of MELK. The gene discussed is MELK; the disease is breast cancer.